Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$340K Sell
2,824
-573
-17% -$66.2K 0.18% 133
2025
Q4
$358K Sell
3,397
-237
-7% -$22.2K 0.1% 220
2025
Q3
$308K Sell
3,634
-176
-5% -$14.5K 0.09% 237
2025
Q2
$302K Sell
3,810
-242
-6% -$19.2K 0.08% 260
2025
Q1
$364K Sell
4,052
-142
-3% -$13.3K 0.1% 216
2024
Q4
$417K Sell
4,194
-230
-5% -$23.7K 0.12% 190
2024
Q3
$502K Sell
4,424
-470
-10% -$55.8K 0.15% 158
2024
Q2
$606K Buy
4,894
+70
+1% +$9.02K 0.2% 113
2024
Q1
$621K Buy
4,824
+2,813
+140% +$347K 0.23% 103
2023
Q4
$219K Sell
2,011
-2,414
-55% -$251K 0.11% 159
2023
Q3
$456K Sell
4,425
-707
-14% -$76.2K 0.55% 51
2023
Q2
$592K Buy
5,132
+1,005
+24% +$114K 0.26% 93
2023
Q1
$439K Sell
4,127
-167
-4% -$18K 0.33% 58
2022
Q4
$476K Buy
+4,294
New +$439K 0.4% 51

Other funds holding MRK

TFB Advisors's MRK Position: Q1 2026 in Review

TFB Advisors reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $66.2K and leaving 2,824 shares worth $340K. The position accounts for 0.18% of the portfolio, ranked #133.

TFB Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $621K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • TFB Advisors held 2,824 shares of Merck worth $340K as of Q1 2026.
  • TFB Advisors sold 573 Merck shares in Q1 2026, an estimated $66.2K.
  • Merck made up 0.18% of TFB Advisors's portfolio in Q1 2026, its #133 holding.
  • TFB Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • TFB Advisors's Merck position peaked at $621K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on TFB Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.